» Articles » PMID: 27468722

MiRNA-regulated Cancer Stem Cells: Understanding the Property and the Role of MiRNA in Carcinogenesis

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2016 Jul 30
PMID 27468722
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Over the last few years, microRNAs (miRNA)-controlled cancer stem cells have drawn enormous attention. Cancer stem cells are a small population of tumor cells that possess the stem cell property of self-renewal. Recent data shows that miRNA regulates this small population of stem cells. In the present review, we explained different characteristics of cancer stem cells as well as miRNA regulation of self-renewal and differentiation in cancer stem cells. We also described the migration and tumor formation. Finally, we described the different miRNAs that regulate various types of cancer stem cells, such as prostate cancer stem cells, head and neck cancer stem cells, breast cancer stem cells, colorectal cancer stem cells, lung cancer stem cells, gastric cancer stem cells, pancreatic cancer stem cells, etc. Extensive research is needed in order to employ miRNA-based therapeutics to control cancer stem cell population in various cancers in the future.

Citing Articles

MicroRNA-21 as a Regulator of Cancer Stem Cell Properties in Oral Cancer.

Jaksic Karisik M, Lazarevic M, Mitic D, Milosevic Markovic M, Riberti N, Jelovac D Cells. 2025; 14(2).

PMID: 39851519 PMC: 11763652. DOI: 10.3390/cells14020091.


The Role of miR-486-5p on CSCs Phenotypes in Colorectal Cancer.

Etzi F, Grinan-Lison C, Fenu G, Gonzalez-Titos A, Pisano A, Farace C Cancers (Basel). 2025; 16(24.

PMID: 39766136 PMC: 11674241. DOI: 10.3390/cancers16244237.


miRNA on the Battlefield of Cancer: Significance in Cancer Stem Cells, WNT Pathway, and Treatment.

Bhagtaney L, Dharmarajan A, Warrier S Cancers (Basel). 2024; 16(5).

PMID: 38473318 PMC: 10931375. DOI: 10.3390/cancers16050957.


Salivary micro RNAs as biomarkers for oropharyngeal cancer.

Weeramange C, Tang K, Barrero R, Hartel G, Liu Z, Ladwa R Cancer Med. 2023; 12(14):15128-15140.

PMID: 37278132 PMC: 10417169. DOI: 10.1002/cam4.6185.


Sulforaphane-Induced Cell Mitotic Delay and Inhibited Cell Proliferation via Regulating CDK5R1 Upregulation in Breast Cancer Cell Lines.

Hung C, Tsai T, Lee K, Hsu Y Biomedicines. 2023; 11(4).

PMID: 37189614 PMC: 10135833. DOI: 10.3390/biomedicines11040996.


References
1.
Shimono Y, Zabala M, Cho R, Lobo N, Dalerba P, Qian D . Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell. 2009; 138(3):592-603. PMC: 2731699. DOI: 10.1016/j.cell.2009.07.011. View

2.
Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K . In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007; 448(7151):318-24. DOI: 10.1038/nature05944. View

3.
Rich J, Guo C, McLendon R, Bigner D, Wang X, Counter C . A genetically tractable model of human glioma formation. Cancer Res. 2001; 61(9):3556-60. View

4.
Ward R, Dirks P . Cancer stem cells: at the headwaters of tumor development. Annu Rev Pathol. 2007; 2:175-89. DOI: 10.1146/annurev.pathol.2.010506.091847. View

5.
Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T . Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer. 2005; 5(9):744-9. DOI: 10.1038/nrc1694. View